Form4insider filings, from the source

SEC Form 4 · accession 0001231589-26-000015

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Paul A Mahon
Officer — EVP & GENERAL COUNSEL
Period of report
Jul 2, 2026
Accepted (ET)
Jul 2, 2026 · 4:32 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJul 2, 2026M8,300$146.03A53,472D
Common StockF2Jul 2, 2026S658$548.0012D52,814D
Common StockF3Jul 2, 2026S258$548.7314D52,556D
Common StockF4Jul 2, 2026S384$550.0235D52,172D
Common StockF5Jul 2, 2026S1,467$551.2961D50,705D
Common StockF6Jul 2, 2026S1,818$552.6068D48,887D
Common StockF7Jul 2, 2026S2,201$553.5167D46,686D
Common StockF8Jul 2, 2026S299$554.4454D46,387D
Common StockF9Jul 2, 2026S990$555.8257D45,397D
Common StockF10Jul 2, 2026S225$556.3589D45,172D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$146.03Jul 2, 2026M8,300DMar 15, 2020Mar 15, 2027Common Stock8,30089,040D

Explanation of responses